Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiyuan Yidavike Pharmaceutical Technology Development is a leading pharmaceutical research and development firm based in Taiyuan, Shanxi Province, China. Established in 2003, the company focuses on the innovation and optimization of Traditional Chinese Medicine (TCM) and chemical drugs, particularly in the fields of oncology, anti-infectives, and pediatrics. It operates as a comprehensive CRO and R&D center, providing services such as API synthesis, formulation development, and generic drug consistency evaluation. Taiyuan Yidavike has been recognized as a National High-Tech Enterprise and has collaborated on significant national research projects, including the "Major New Drug Discovery" initiative for pediatric medications. The company is known for its work on products like Qingfei Zhisou oral liquid and has successfully transferred over 200 pharmaceutical technologies to domestic manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiyuan Yidavike Medical Technology Development.